Certified Tumor Registrar (CTR) 2025 Complete Practice Exam

Question: 1 / 400

What is the primary purpose of neoadjuvant treatment?

To eliminate cancer cells before surgery

To shrink the tumor to increase the possibility of resectability

The primary purpose of neoadjuvant treatment is to shrink the tumor to increase the possibility of resectability. Neoadjuvant therapy, which may include chemotherapy, radiation, or hormonal therapy, is administered before the main treatment, typically surgery. By reducing the size of the tumor, neoadjuvant treatment can make it easier to remove the cancerous tissue, improving surgical outcomes and allowing for more conservative surgical techniques.

Additionally, this approach can also help assess the tumor's response to the treatment before surgery. A successful reduction in tumor size can lead to better surgical margins and a lower likelihood of cancer recurrence, ultimately improving prognosis. The focus here is not just on eliminating cancer cells (though this is a secondary effect) but directly on making the surgery more feasible and successful.

Get further explanation with Examzify DeepDiveBeta

To enhance recovery post-surgery

To improve the patient's overall health

Next Question

Report this question

Download Certified Tumor Registrar (CTR) 2025 Complete Practice Exam PDF Study Guide
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy